Ensign Peak Advisors, Inc Dynavax Technologies Corp Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
BUY
$13.17 - $20.94 $391,807 - $622,965
29,750 New
29,750 $419,000
Q4 2020

Feb 12, 2021
SELL
$3.73 - $5.6 $718,375 - $1.08 Million
-192,594 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$4.32 - $11.7 $832,006 - $2.25 Million
192,594 New
192,594 $832,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email